After adjustment for confounders, NAFLD (OR, 4.7; 95% CI, 1.5–14.8; padj = 0.007), but not the PNPLA3 gene variant, emerged as the main independent predictor of renal dysfunction. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.